Organ sparing treatment for penile cancer using a 3D-printed high-dose-rate brachytherapy applicator

• Published in: Brachytherapy Vol. 22; no. 5; pp. 580 - 585
• Main Authors: Lee, Hugh H.C., Chiu, Tsuicheng D., Hrycushko, Brian, Xiong, Zhenyu, Hudak, Steve, Woldu, Solomon, Mauck, Ryan, Corwin, Terry, Meng, Xiaosong, Margulis, Vitaly, Desai, Neil, Folkert, Michael R., Garant, Aurelie
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-09-2023
• Subjects: 3D printed applicator; Custom bolus; HDR brachytherapy; Penile cancer; Plesiotherapy; SCC; Penile cancer; CTV; PLA; Plesiotherapy; 3D printed applicator; HDR; DVH; SLA; FDM; HDR brachytherapy; Custom bolus
• ISSN: 1538-4721; 1873-1449
• DOI: 10.1016/j.brachy.2023.06.001

We present a case study of the treatment of localized squamous cell carcinoma on the glans penis with a custom-fabricated high-dose-rate (HDR) brachytherapy applicator.
A cylindrically shaped applicator was fabricated with eight embedded channels suitable for standard plastic brachytherapy catheters. An additional custom silicone bolus/sleeve was designed to be used with the 3D-printed applicator to provide an additional offset from the source to skin to reduce the surface dose and for patient comfort.
The patient (recurrent cT1a penile cancer) underwent CT simulation, and the brachytherapy plan was created with a nominal prescription dose of 40 Gy in 10 fractions given bidaily to the surface, and 35 Gy at 5 mm depth. Dose coverage to the clinical target volume was 94% (D90). Most fractions were treated with only 5-10 min of setup time. Follow up visits up to 1 year showed no evidence of disease with no significant changes in urinary and sexual function and limited cosmetic detriment to the patient.
Patient-specific organ-sparing HDR plesiotherapy using 3D printing technology can provide reliable and reproducible patient setup and may be effective in achieving disease control for superficial penile cancer, although preserving patient quality of life.